Second Neoplasms Following High-dose Chemotherapy and Autologous Stem Cell Transplantation for Malignant Lymphomas: A Report of Six Cases in a Cohort of 171 Patients from a Single Institution

References

• Bathia S., Robinson L., Oberlin O., Greenberg M., Bunin G., Fossati-Bellani F., Meadows A.T. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996; 334: 745–751
   PubMed Web of Science ®Google Scholar
• Cimino G., Papa G., Tura S., Mazza P., Rossi-Ferrini P.L., Bosi A., Amadoris S., D'Arcangelo E., Giannarelli D., Mandelli F. Second primary cancer following Hodgkin's disease: updated results of a Italian multicentric study. J Clin Oncol 1991; 9: 432–437
   PubMed Web of Science ®Google Scholar
• Travis L.B., Curtis R.E., Glimelius B., Holowaty E., Van Leewen F.E., Lynch C.F., Adami J., Gospodarowicz M., Wacholder S., Inskip P., Tucker M.A., Fraumeni J.F., Boice J.D. Second cancers among long term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst 1993; 85: 1932
   PubMed Web of Science ®Google Scholar
• Boshoff C., Begent R.H., Oliver R.T., Rustin G.J., Newlands E.S., Andrews R., Skelton M., Holden L., Ong J. Secondary tumors following etoposide containing therapy for germ cell cancer. Annals of Oncology 1995; 6(1)35–40
   PubMed Web of Science ®Google Scholar
• Socie G. Secondary Malignancies. Current Opinion in Hematology 1996; 3: 466
   PubMedGoogle Scholar
• Dumontet C., Bastion Y., Felman P., French M., Peaud P.Y., Coiffier B. Long-term outcome and sequelae in aggressive lymphoma patients treated with the LNH-80 regimen. Annals of Oncology 1992; 3: 639–644
   PubMed Web of Science ®Google Scholar
• Travis L.B., Curtis R.E., Boice J.D., Hankey B.F., Fraumeni J.F. Second cancers following NHL. Cancer 1991; 67: 2002–9
   PubMed Web of Science ®Google Scholar
• Curtis R.E., Rowlings P.A., Deeg H.J., Shriner D.A., Socie G., Travis L.B., Horowitz M.M., Witherspoon R.P., Hoover R.N., Sobocinski K.A., Fraumeni J.F., Boice J.D. Solid cancers after bone marrow transplantation. N Engl J Med 1997; 336: 891
   PubMed Web of Science ®Google Scholar
• Bathia S., Ramsay N., Steinbuch M., Dusenbery K.Z., Shapiro R.S., Weisdorf D.J., Robinson L.L., Miller J.S., Neglia J.P. Malignant neoplasms following Bone Marrow Transplantation. Blood 1996; 87: 3633–3639
   PubMed Web of Science ®Google Scholar
• Lowsky R., Lipton J., Fyles G., Minden M., Meharchand J., Tejpar I., Atkins H., Sutcliffe S., Messner H. Secondary malignancies after bone marrow transplantation in adults. J Clin Oncol 1994; 12: 2187–2191
   PubMed Web of Science ®Google Scholar
• Henry-Amar M., Joly F. Late complications after Hodgkin's disease. Annals of Oncology 1996; 7(suppl.4)S115–S126
   PubMed Web of Science ®Google Scholar
• Fisher R.L., DeVita V.T., Bostick F., Vanhaeien C., Howser D.M. Persistent immunological abnormalities in long term survivors of advanced Hodgkin's disease. Ann Intern Med 1980; 92: 595–599
   PubMed Web of Science ®Google Scholar
• Deeg H.J., Witherspoon R.P. Risk factors for the development of secondary malignancies after marrow transplantation. Hematol Oncol Clin North Am 1993; 7: 417
   PubMed Web of Science ®Google Scholar
• Chopra R., Mc Millian A.K., Linch D.C., Yuklea S., Taghipour G., Pearce R., Ptterson K.G., Goldstone A.H. The place of High-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease: a single-center eight-year study of 155 patients. Blood 1993; 81: 1137–1145
   PubMed Web of Science ®Google Scholar
• Philip T., Gugliemi C., Hagenbeek A., Somers R., Van Der Lelie H., Bron D., Sonneveld P., Gisselbrecht C., Cahn J.Y., Harousseau J.L., Coiffier B., Biron P., Mandelli F., Chauvin F. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. New Engl JMed 1995; 1: 1540–45
   Web of Science ®Google Scholar
• Haioun C., Lepage E., Gisselbrecht C., Bastion Y., Coiffier B., Brice P., Bosly A., Dupriez B., Nouvel C., Tilly H., Lederlin P., Biron P., Briere J., Gaulard P., Reyes F., 'Groupe d'Etudes des Lymphomes de l'Adulte'. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor risk aggressive non-Hodgkin's lymphomas: updated results of the prospective study LNH87-2. J Clin Oncol 1997; 15: 1131–1135
   PubMed Web of Science ®Google Scholar
• Rohatiner A. Myelodysplasia and acute myelogenous leukemia after myeloablative therapy with autologous stem-cell transplantation. J Clin Oncol 1994; 12: 2521–2525
   PubMed Web of Science ®Google Scholar
• Hartmann O., Oberlin O., Lemerle J., Maraninchi D., Gastaut J.A., Mascret B., Sebahoun G., Carcassone Y. Acute leukemia in two patients treated with High-dose Melphalan and autologous marrow transplantation for malignant solid tumors. J Clin Oncol 1984; 12: 1424–1425, correspondence
   Google Scholar
• Andre M., Henry-Amar M., Blaise D., Colombat P., Fleury J., Milpied N., Cahn J.Y., Pico J.L., Bastion Y., Kuentz M., Biron P., Fermé C., Gisselbrecht C. Incidence of second cancers (SC) and causes of death after autologous stem cell transplantation (ASCT) for Hodgkin's disease (HD). Blood 1995; 86(suppl 1)640a
   Google Scholar
• Gianni A.M., Bregni M., Siena S., Brambilla C., Di Nicola M., Lombardi F., Gandola L., Tarella C., Pileri A., Ravagnani G., Valagussa P., Bonadonna G. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 1997; 336: 1290–1297
   PubMed Web of Science ®Google Scholar
• Mills W., Chopra R., Mc Millan A., Pearce R., Linch D.C., Goldstone A.H. BEAM Chemotherapy and Autologous Bone Marrow Transplantation for patients with relapsed or refractory Non Hodgkin's Lymphoma. J Clin Oncol 1995; 13: 588–595
   PubMed Web of Science ®Google Scholar
• Kaplan E.L., Meier P. Non parametric estimation from incomplete observations. Am Star Assoc 1979; 53: 457–81
   Google Scholar
• Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163–168
   PubMedGoogle Scholar
• Benhamou E., Laplanche A., Wartelle M., Faivre J., Gignoux M., Menegoz F., Robillard J., Schaffer P., Schraub S., Flamant R. Incidence des cancers en France 1978-1982. Les éditions INSERM. 1982
   Google Scholar
• Breslow N.E., Day N.E. Statistical methods in cancer research.-The design and analysis of cohort studies. IARC Scientific publications 1987; Vol. 2: 82
   Google Scholar
• Craig J.R., Peters R.L., Edmonson H.A. Fibrolamellar carcinoma of the liver. Cancer 1980; 46: 312–319
   Web of Science ®Google Scholar
• Finch S.C. The study of atomic bomb survivors in Japan. Am J Med 1979; 66: 899–901
   PubMed Web of Science ®Google Scholar
• Linch D.C., Knott L.J., Thomas P.M. T-cell regeneration after allogeneic and autologous bone marrow transplantation. Br J Haematol 1983; 53: 451–458
   PubMed Web of Science ®Google Scholar
• De Vita V.T., Hubbard S.M. Hodgkin's disease. N Engl J Med 1993; 328: 560–565
   PubMedGoogle Scholar
• Stoppa A.M., Bouabdallah R., Chabannon C., Novakovitch G., Vey N., Camerlo J., Blaise D., Xerri L., Resbeut M., Di Stefano D., Bardou V.J., Gastaut J.A., Maraninchi D. Intensive sequential chemotherapy with repeated stem cell support for untreated poor prognosis non Hodgkin's lymphoma. Clin Oncol 1997; 15: 1722–1729
   Web of Science ®Google Scholar